文献速递咽喉与嗓音小儿耳鼻咽喉

无创呼吸支持作为重度喉软化气管切开替代方案

Noninvasive Respiratory Support as an Alternative to Tracheostomy in Severe Laryngomalacia.
PubMed 文献 · Laryngoscope · 2021-10-29

29例(15%)接受无创呼吸支持(NRS),平均年龄3±2个月,平均疗程6±11个月,全部成功且无一例行气管切开。结论认为NRS安全,可避免气管切开,尤其适用于内镜手术失败、术前呼吸衰竭和/或严重共病者。

要点

  • NRS可用于重度喉软化,29例均成功且无需气管切开。
  • 内镜手术失败、术前氧合异常或共病禁忌手术者可考虑NRS。
  • 新生儿呼吸窘迫、神经共病等是NRS的预测因素。

核心结论

  • NRS是安全措施,可避免重度喉软化患者行气管切开。
  • 尤其适用于内镜手术失败、术前呼吸衰竭和/或严重共病者。

研究设计与样本

  • 平均年龄4±5个月,平均体重4,925±1,933 g。

主要发现

  • 183例(97%)行内镜下双侧声门上成形术,成功159例(87%)。
  • 29例(15%)启动NRS,平均年龄3±2个月(范围1-11个月)。
  • NRS成功用于所有患者,平均疗程6±11个月,无一例行气管切开。
  • NRS指征:手术失败后15例(52%)、术前因夜间气体交换异常9例(31%)、因共病禁忌内镜手术而仅用NRS 5例(17%)。
  • 单因素分析显示NRS预测因素:新生儿呼吸窘迫(P=.003)、神经共病(P<.001)、相关喉部异常(P<.001)、心脏手术(P=.039)、内镜手术修正(P=.007)、营养支持(P<.001)。

关键数值与推荐

  • NRS成功用于29例(15%)重度喉软化患儿,平均疗程6±11个月。
  • 内镜手术成功159/183例(87%),失败者中15例(52%)接受NRS。

临床怎么用

  • 对重度喉软化,尤其内镜手术失败、术前呼吸衰竭或严重共病者,可考虑NRS替代气管切开。
  • 需关注新生儿呼吸窘迫、神经共病、喉部异常等NRS预测因素。

局限性

  • 单中心回顾性研究,证据等级为3。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES/HYPOTHESIS: To analyze the role of noninvasive respiratory support (NRS) as an alternative to tracheostomy in the management of severe laryngomalacia. STUDY DESIGN: We conducted a monocentric retrospective study in a tertiary pediatric care center. METHODS: All children under the age of 3 years with severe laryngomalacia, treated between January 2014 and December 2019, were included. Patient demographics, medical history, nutrition, surgery, NRS, and outcome were reviewed. Predictors for NRS were analyzed. RESULTS: One hundred and eighty-eight patients were included. Mean age was 4 ± 5 months and mean weight was 4,925 ± 1,933 g. An endoscopic bilateral supraglottoplasty was performed in 183 (97%) patients and successful in 159 (87%). NRS was initiated in 29 (15%) patients at a mean age of 3 ± 2 months (1-11 months): 15 (52%) patients were treated with NRS after surgical failure, 9 (31%) were treated with NRS initiated prior to surgery because of abnormal overnight gas exchange, and 5 (17%) were treated exclusively with NRS due to comorbidities contraindicating an endoscopic procedure. NRS was successfully performed in all patients with a mean duration of 6 ± 11 months. No patient required a tracheostomy. Univariate analysis identified the following predictors of NRS: neonatal respiratory distress (P = .003), neurological comorbidity (P < .001), associated laryngeal abnormality (P < .001), cardiac surgery (P = .039), surgical endoscopic revision (P = .007), and nutritional support (P < .001). CONCLUSION: NRS is a safe procedure, which may avoid a tracheostomy in severe laryngomalacia, in particular, in case of endoscopic surgery failure, respiratory failure before surgery, and/or severe co-morbidity. LEVEL OF EVIDENCE: 3 Laryngoscope, 132:1861-1868, 2022.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Veroul E, Amaddeo A, Leboulanger N, et al. Noninvasive Respiratory Support as an Alternative to Tracheostomy in Severe Laryngomalacia. Laryngoscope. 2021. PMID: 34713900. doi:10.1002/lary.29928

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。